Trades on 1 secondary market
Earli
Earli is a biotech company using AI-designed genetic switches for early cancer detection and treatment. Its synthetic-biomarker technology forces cancer cells to reveal themselves for earlier, more accurate detection, and can program cancer cells to self-destruct while sparing healthy tissue. Founde
Earli is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.